In the last decades, several reports have shown that lysosomal membrane proteins, particularly lysosome-associated membrane proteins (LAMPs) 1 and 2 (LAMP1 and LAMP2), are deregulated in different cancer types [6, 7] and their expression has been associated with drug resistance [8, 9]. Here, LAMP1 is linked to cancer.